[{"address1": "1180 Seminole Trail", "address2": "Suite 495", "city": "Charlottesville", "state": "VA", "zip": "22901", "country": "United States", "phone": "434 422 9800", "website": "https://www.adialpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Mr. Cary John Claiborne MBA", "age": 62, "title": "CEO, President & Director", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 728307, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Bankole A. Johnson DSc, FRCPsych, M.D., M.Phil, Ph.D.", "age": 63, "title": "Founder & Chief Medical Officer", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 435000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph A. M. Truluck M.B.A., MBA", "age": 45, "title": "CFO, Treasurer & Secretary", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 358486, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tony  Goodman", "age": 59, "title": "COO & Director", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 33000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John R. Martin J.D.", "title": "Chief Legal Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Catherine  Fratila", "title": "Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.71, "open": 1.67, "dayLow": 1.622, "dayHigh": 1.76, "regularMarketPreviousClose": 1.71, "regularMarketOpen": 1.67, "regularMarketDayLow": 1.622, "regularMarketDayHigh": 1.76, "beta": 1.527, "forwardPE": -1.0880502, "volume": 139634, "regularMarketVolume": 139634, "averageVolume": 6518090, "averageVolume10days": 1159340, "averageDailyVolume10Day": 1159340, "bid": 1.71, "ask": 1.76, "bidSize": 300, "askSize": 1000, "marketCap": 7014908, "fiftyTwoWeekLow": 0.77, "fiftyTwoWeekHigh": 14.0, "fiftyDayAverage": 1.694, "twoHundredDayAverage": 2.62855, "currency": "USD", "enterpriseValue": 4187827, "floatShares": 3937716, "sharesOutstanding": 4054860, "sharesShort": 1009702, "sharesShortPriorMonth": 105627, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.249, "heldPercentInsiders": 0.04038, "heldPercentInstitutions": 0.06525, "shortRatio": 0.14, "shortPercentOfFloat": 0.2575, "impliedSharesOutstanding": 4054860, "bookValue": 2.455, "priceToBook": 0.7046844, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -7001890, "trailingEps": -4.91, "forwardEps": -1.59, "lastSplitFactor": "1:25", "lastSplitDate": 1691366400, "enterpriseToEbitda": -0.608, "52WeekChange": -0.7964706, "SandP52WeekChange": 0.21080327, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ADIL", "underlyingSymbol": "ADIL", "shortName": "Adial Pharmaceuticals, Inc", "longName": "Adial Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1532698200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "a144d6a7-1775-3bb1-b1ca-599a0edca1eb", "messageBoardId": "finmb_112638788", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.73, "targetHighPrice": 26.0, "targetLowPrice": 8.0, "targetMeanPrice": 17.0, "targetMedianPrice": 17.0, "recommendationMean": 2.3, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 2827082, "totalCashPerShare": 0.697, "ebitda": -6887383, "quickRatio": 4.329, "currentRatio": 4.898, "returnOnAssets": -0.82238996, "returnOnEquity": -1.90268, "freeCashflow": -3214454, "operatingCashflow": -6806809, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-26"}]